The Case For

Rethinking the Fundamental
Biology of Aging

Understanding the root causes of aging with innovation and collaboration.

view the plan

Our Mission

The Thalion Initiative is focused on improving the fundamental understanding of aging biology to enhance drug development and therapeutic interventions. By integrating diverse scientific disciplines, we aim to advance research methodologies and develop practical applications for aging-related conditions.

Key Objectives

Investigate fundamental mechanisms of aging

Improve predictability in biology

Enforce interdisciplinary collaboration for more effective research approaches

Why Thalion?

We apply a first-principles approach to aging biology, incorporating comparative biology, synthetic biology, and embryonic rejuvenation to address knowledge gaps. We prioritize open access to data and tools, enabling collaborative progress across the scientific community.

Understanding the Challenge

Factors Contributing to Stagnation
in Biomedical Innovation:

Eroom’s Law

Drug development costs continue to rise, while success rates decline

High Failure Rates

Only a small fraction of pre-clinical candidates lead to approved therapeutics

Limited Disruptive Progress

Most scientific advancements build incrementally rather than introducing fundamentally new approaches

Dive Deeper
a close up of a circuit board

The Role of Aging Biology

Aging is a key driver of many chronic diseases, including cancer, cardiovascular conditions, and neurodegeneration. Addressing aging mechanisms will lead to broader health benefits compared to treating individual diseases in isolation.

Our Approach

We employ a systems-based methodology to improve aging research by focusing on

Validating the Central Dogma of Biology

New research to elucidate the central dogma of biology.

Advanced Tool Development

Improving real-time measurement technologies for aging biomarkers while enhancing predictive modeling and simulation capabilities.

Experimental Insights

Identifying shared biological mechanisms across species to improve therapeutic predictability through quantitative modeling.

Dive Deeper

A Phased RESEARCH Strategy

Phase I (2025–2033)

Foundational Research

Tools, datasets, and model development based on identified gaps from the Advisory Group. This Phase will prepare the tools needed to fill in the fundamental gaps in knowledge as it is currently understood.
Phase II (2033–2038)

Translational Delivery Phase

Focus on advancing models and developing tools for delivery mechanics of gene therapies and protein
biologic payloads.
Phase III (2035–2040)

Therapeutic Support Phase

The Initiative will advance its learnings towards commercialization including licensing of its technology.
back
next
phase I
phase II
phase III

focus areas

Comparative Biology

Studying longevity and disease resistance in different species.

Synthetic Biology

Engineering biological functions to mitigate aging mechanisms.

Advanced Tooling

Developing new measurement and modeling technologies for aging research.

Embryonic Rejuvenation

Investigating natural regenerative processes in early development.

Dive deeper